Day 9 | NEJM Resident 360

@NEJM Ask the Authors & Experts: Prospective Validation of a 21-Gene Expression Assay in Breast Cancer & Biology before Anatomy in Early Breast Cancer

Q&A has ended

Authors
Joseph Sparano, MD

Associate Chairman for Clinical Research, Dept of Oncology, Montefiore Medical Center

Joseph Sparano, MD

Joseph Sparano, MD

Associate Chairman for Clinical Research, Dept of Oncology, Montefiore Medical Center

Associate Chairman for Clinical Research, Dept of Oncology, Montefiore Medical Center
Charles Geyer, MD

Harrigan, Haw, Luck Families Chair in Cancer Research, Virginia Commonwealth University Massey Cancer Center

Charles Geyer, MD

Charles Geyer, MD

Harrigan, Haw, Luck Families Chair in Cancer Research, Virginia Commonwealth University Massey Cancer Center

Harrigan, Haw, Luck Families Chair in Cancer Research, Virginia Commonwealth University Massey Cancer Center
Thomas Saphner, MD, FACP

Co-PI, NCORP Community Site at Aurora Health Center

Thomas Saphner, MD, FACP

Thomas Saphner, MD, FACP

Co-PI, NCORP Community Site at Aurora Health Center

Co-PI, NCORP Community Site at Aurora Health Center
Clifford Hudis, MD

Chief of the Breast Medicine Service, Memorial Sloan Kettering Cancer Center

Clifford Hudis, MD

Clifford Hudis, MD

Chief of the Breast Medicine Service, Memorial Sloan Kettering Cancer Center

Chief of the Breast Medicine Service, Memorial Sloan Kettering Cancer Center

Experts
Nadine Tung, MD

Director, Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center

Nadine Tung, MD

Nadine Tung, MD

Director, Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center

Director, Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center
Douglas Blayney, MD

Associate Chief for Clinical Affairs, Medical Oncology, Stanford SOM

Douglas Blayney, MD

Douglas Blayney, MD

Associate Chief for Clinical Affairs, Medical Oncology, Stanford SOM

Associate Chief for Clinical Affairs, Medical Oncology, Stanford SOM
Sandra Shin, MD

Chief of Breast Pathology, Weill Cornell Medicine

Sandra Shin, MD

Sandra Shin, MD

Chief of Breast Pathology, Weill Cornell Medicine

Chief of Breast Pathology, Weill Cornell Medicine
Melinda Telli, MD

Assistant Professor of Medicine, Medical Oncology at Stanford University School of Medicine

Melinda Telli, MD

Melinda Telli, MD

Assistant Professor of Medicine, Medical Oncology at Stanford University School of Medicine

Assistant Professor of Medicine, Medical Oncology at Stanford University School of Medicine
Kevin Hughes, MD, FACS

Co-Director, Avon Comprehensive Breast Evaluation Center, MGH

Kevin Hughes, MD, FACS

Kevin Hughes, MD, FACS

Co-Director, Avon Comprehensive Breast Evaluation Center, MGH

Co-Director, Avon Comprehensive Breast Evaluation Center, MGH
Roisin Connolly, MB, BCh

Assistant Professor of Oncology at Johns Hopkins

Roisin Connolly, MB, BCh

Roisin Connolly, MB, BCh

Assistant Professor of Oncology at Johns Hopkins

Assistant Professor of Oncology at Johns Hopkins
Daniel Stover, MD

Instructor in Medicine, Dana-Farber Cancer Institute

Daniel Stover, MD

Daniel Stover, MD

Instructor in Medicine, Dana-Farber Cancer Institute

Instructor in Medicine, Dana-Farber Cancer Institute
Meghan Karuturi, MD

Assistant Professor, Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center

Meghan Karuturi, MD

Meghan Karuturi, MD

Assistant Professor, Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center

Assistant Professor, Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center
Daniel Silver, MD, PhD

Assistant Professor of Medicine, Dana-Farber Cancer Institute

Daniel Silver, MD, PhD

Daniel Silver, MD, PhD

Assistant Professor of Medicine, Dana-Farber Cancer Institute

Assistant Professor of Medicine, Dana-Farber Cancer Institute
Phoebe Freer, MD

Assistant Radiologist at Massachusetts General Hospital/ Harvard Medical School

Phoebe Freer, MD

Phoebe Freer, MD

Assistant Radiologist at Massachusetts General Hospital/ Harvard Medical School

Assistant Radiologist at Massachusetts General Hospital/ Harvard Medical School

Lead Moderators
Vishal Punwani, MD

CEO of Sophya, Resident Physician, Mentor at Harvard and Oxford Universities

Vishal Punwani, MD

Vishal Punwani, MD

CEO of Sophya, Resident Physician, Mentor at Harvard and Oxford Universities

CEO of Sophya, Resident Physician, Mentor at Harvard and Oxford Universities

Moderators
Sheheryar Kabraji, BM BCh

Physician-scientist at Dana Farber Cancer Institute studying residual disease in breast cancer.

Sheheryar Kabraji, BM BCh

Sheheryar Kabraji, BM BCh

Physician-scientist at Dana Farber Cancer Institute studying residual disease in breast cancer.

Physician-scientist at Dana Farber Cancer Institute studying residual disease in breast cancer.
Katie Spina, MD, PhD

Intern, Department of Medicine at Mount Auburn Hospital

Katie Spina, MD, PhD

Katie Spina, MD, PhD

Intern, Department of Medicine at Mount Auburn Hospital

Intern, Department of Medicine at Mount Auburn Hospital
Arthur Su

MD Program at Boston University School of Medicine; Summer Translational Research Fellowship at Dana-Farber Cancer Institute

Arthur Su

Arthur Su

MD Program at Boston University School of Medicine; Summer Translational Research Fellowship at Dana-Farber Cancer Institute

MD Program at Boston University School of Medicine; Summer Translational Research Fellowship at Dana-Farber Cancer Institute

All Questions & Answers
Question: Day 9

NEJM Resident 360 · Discussion

@NEJM Ask the Authors & Experts: Prospective Validation of a 21-Gene Expression Assay in Breast Cancer & Biology before Anatomy in Early Breast Cancer

Boston, MA
Khan Academy